Zydus oxybutynin extended-release tablets recalled nationwide for failed stability testing
Zydus Pharmaceuticals is recalling specific lots of oxybutynin chloride extended-release 10 mg tablets nationwide due to out-of-specification dissolution test results at the 6-month stability timepoint. The affected tablets may not release medication properly.
- Product
- OXYBUTYNIN — OXYBUTYNIN (OXYBUTYNIN)
- Category
- Drug
- Distribution
- Distributed nationwide